Pandemic Timeline

The Pirbright Institute files patent US10130701: Coronavirus

The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.

Patent US10130701B21

Sources:

Related:

 

 

Comments are closed.